Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer

• Published in: Cancers Vol. 16; no. 4; p. 745
• Main Authors: Tâlvan, Constantin-Dan, Budișan, Liviuța, Tâlvan, Elena-Teodora, Grecu, Valentin, Zănoagă, Oana, Mihalache, Cosmin, Cristea, Victor, Berindan-Neagoe, Ioana, Mohor, Călin Ilie
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024
• Subjects: Analysis; Biomarkers; Blood; Cancer; Cancer therapies; Colon cancer; Colorectal cancer; Cytokines; Development and progression; Disease; Enzyme-linked immunosorbent assay; Immune system; Inflammation; Interleukins; Large intestine; Medical prognosis; Metastasis; Oncology, Experimental; Patients; Proteins; Radiation; Serum levels; Tumor staging; Romania; United States > US; cancer staging; gender; biomarkers; colon cancer; serum; correlations; age; interleukins
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers16040745

This research investigated the serum levels of three interleukins (IL8, IL17A, and IL33) and the possible relationships between them in healthy people and colon cancer patients at different stages. This study involved 82 participants, 42 of whom had colon cancer and 40 were healthy individuals. The cancer patients were classified into four groups according to the TNM staging classification of colon and rectal cancer. Serum levels of the interleukins were measured by the ELISA test. The data were analyzed statistically to compare the demographic characteristics, the interleukin levels across cancer stages, and the correlation between interleukins in both groups. The results showed that women had more early-stage colon cancer diagnoses, while men had more advanced-stage cancer diagnoses. Stage two colon cancer was more common in older people. Younger people, men, and those with early-stage colon cancer had higher levels of interleukins. The levels of IL8 and IL17A were higher in the cancer group, while the level of IL33 was higher in the healthy group. There was a strong correlation between IL8 and IL17A levels in both groups ( = 0.001). IL17A influenced the level of IL33 in the cancer group ( = 0.007). This study suggested that cytokine variation profiles could be useful for detecting colon cancer and predicting its outcome.